Skip to main content
SpringerLink
Log in

Fibrinogen half-life in children with cyanotic congenital heart disease

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Fibrinogen half-life was determined in 3 healthy individuals and in 17 children with cyanotic congenital heart disease. Fibrinogen half-life was normal in the healthy individuals and shortened in 9 of the 17 patients. The simultaneously performed coagulation tests were often pathological but did not lead to a clear diagnosis of the haemostatic defect and did not correlate with the fibrinogen half-life. Significant correlations were found between fibrinogen half-life and red cell count (P<0.001), packed cell volume (P<0.001), mean corpuscular volume of the red cell (P<0.001), platelet count (P<0.01), aortic oxygen saturation (P<0.001), base excess (P<0.01), and maximal amplitude of the thrombelastography (P<0.001). The results indicate a definite relationship between the hypoxaemia and the frequently observed disturbance of haemostasis in cyanotic heart disease. The chronic hypoxaemia causes a partly compensated intravascular coagulation with increased fibrinogen metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brodsky J, Gill DM, Lusch CJ (1968) Fibrinolysis in congenital heart disease. Preoperative treatment with EACA. Ann Int Med 68:1165

    Google Scholar 

  2. Collen D, Tydgat GN, Claeys H, Piessens R (1972) Metabolism and distribution of fibrinogen I. Br J Haematol 22:681–700

    Google Scholar 

  3. Collen D, Semerano N, Verstraete M (1974) The fibrinolytic pathway of fibrinogen catabolism: A replay. Thromb Res 4:491–496

    Google Scholar 

  4. Dennis LH, Stewart JL, Conrad ME (1967) Heparin treatment of hemorrhagic diathesis in cyanotic congenital heart disease. Lancet I: 1088–1089

    Google Scholar 

  5. Edgington TS (1975) Fibrinogen and fibrin degradation products. Their differentiation. Thromb Diathes Haemorrh 34:671–676

    Google Scholar 

  6. Edgington TS, Plow EF (1973) Coupling of coagulation and fibrinolytic systems approached through immunologic discrimination between fibrin and fibrinogen cleavage fragments. Thromb Diathes Haemorrh [Suppl] 54:211–222

    Google Scholar 

  7. Ekert H, Gilchrist GS, Stanton R (1970) Hemostasis in cyanotic congenital heart disease. J Pediatr 76:221–231

    Google Scholar 

  8. Gaarder A, Jehnsen J, Laland S, Hellem A, Owren P (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature (Lond) 192:531–534

    Google Scholar 

  9. Göbel U, Mak SY, Petrich C, Voss H von (1977) Erworbene Gerinnungsstörungen im Kindesalter. Bücherei des Pädiaters 78, Enke, Stuttgart, S 149–157

    Google Scholar 

  10. Goldschmidt B, Sarkadi B, Gardos G, Matary A (1974) Platelet production and survival in cyanotic congenital heart disease. Scand J Haematol 13:110–115

    Google Scholar 

  11. Goldschmidt B, Kun E (1973) Platelet adhesiveness in cyanotic congenital heart disease. Academic Scientarum Hung 14:99–103

    Google Scholar 

  12. Gralnick HR (1970) Epsilon-Aminocapronic acid in preoperative correction of haemostatic defect in cyanotic congenital heart disease. Lancet I:1204–1205

    Google Scholar 

  13. Green D (1971) Correction of hemostatic defect in cyanotic congenital heart disease. Lancet I:486–487

    Google Scholar 

  14. Hartert H (1952) Klinische Blutgerinnungsstudien mit der Thrombelastographie. I. Physiologische und klinische Grundlagen der Thrombelastographie. Dtsch Arch Klin Med 199:284–311

    Google Scholar 

  15. Hellem AL (1960) The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest [Suppl] 51:1–117

    Google Scholar 

  16. Henriksson P, Värendh G, Lundström NR (1979) Haemostatic defects in cyanotic congenital heart disease. Br Heart J 41:23–27

    Google Scholar 

  17. Ihenacho HNC, Breeze GR, Fletcher DJ, Stuart J (1973) Consumption coagulopathy in congenital heart disease. Lancet I:231–234

    Google Scholar 

  18. Jackson DP (1964) Hemorrhagic diathesis in patients with cyanotic congenital heart disease; preoperative management. Ann NY Acad Sci 115:235

    Google Scholar 

  19. Iølster NJ (1970) Blood coagulation in children with cyanotic congenital heart disease. Acta Paediat Scand 59:551–557

    Google Scholar 

  20. Komp DM, Sparrow AW (1970) Quantitation of secondary fibrinolysis in cyanotic heart disease. J Pediatr 77:679–682

    Google Scholar 

  21. Kuehl KS, Perry LW, Scott LP (1971) Thrombosis of the inferior vena cava in patients with cyanotic congenital heart disease. J Pediatr 79:430–435

    Google Scholar 

  22. Kummer H, Gurtner HP, Bucher U (1964) Thrombocytopenie bei chronischem Cor pulmonale und cyanotischen Herzvitien. Schweiz Med Wochenschr 94:1334–1338

    Google Scholar 

  23. Laborit H, Ornellas MR (1969) Hyperlactacidemia as a factor of thrombocyte adhesiveness. Experientia (Basel) 25:1035

    Google Scholar 

  24. Linderkamp O, Mayr S, Sengespeik C, Klose H, Betke K (1976) Eisenmangel bei Vorliegen von cyanotischen Herzvitien: Eine Untersuchung für cerebrale Komplikationen. Monatsschr Kinderheilk 124:301–302

    Google Scholar 

  25. Lipinski B, Lipinski I, Gurewich V (1974) The fibrinolytic pathway of fibrinogen-catabolism. Additional comments. Thromb Res 4:891–894

    Google Scholar 

  26. Mancini G, Carbonara AO, Heremens JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 2:235–254

    Google Scholar 

  27. Matheson NA (1969) Factors in the tissue perfusion. The microcirculation in shock. Postgrad Med J 45:530–533

    Google Scholar 

  28. Maurer HM, McCue CM, Robertson LW, Haggins JC (1975) Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction. Am J Cardiol 35:831–835

    Google Scholar 

  29. Phornphutkul C, Rosenthal A, Nadas A, Berenberg W (1973) Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol 32:329–334

    Google Scholar 

  30. Plow EP, Edgington TS (1973) Discriminating neoantigenic differences between fibrinogen and fibrin derivates. Proc Natl Acad Sci USA 70:1169–1173

    Google Scholar 

  31. Reimers HJ, Packham MA, Kinlough-Rathbone RO (1973) Effects of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol 25:675–689

    Google Scholar 

  32. Schreiber R, Lorenz HP (1980) Plättchenaggregation bei Kindern mit zyanotischen Herzfehlern. In: Voss H von, Göbel U (Hrsg) Praktische Anwendung der Thrombozytenfunktionsdiagnostik. G Thieme, Stuttgart New York, pp 211–218

    Google Scholar 

  33. Schwick HG, Störiko K (1966) Beiträge zur Diagnostik von Gerinnungsstörungen. Laboratoriumsblätter für die medizinische Diagnostik; Behringwerke AG, Marburg

    Google Scholar 

  34. Straub PW (1971) Chronic intravascular coagulation. Acta Med Scand [Suppl] 526

  35. Sunder-Plassmann L, Kloevekorn WP, Messmer K (1971) Blutviskosität und Hämodynamik bei Anwendung kolloidaler Volumenersatzmittel. Der Anaesthesist 20:172–180

    Google Scholar 

  36. von Kaula KN, Paton BC, Rosenkrantz JG, von Kaula E, Wasantapruek S (1967) Preoperative correction of anticoagulation in tetralogy of Fallot. Arch Surg 94:107

    Google Scholar 

  37. Waldmann JD, Czapek EE, Paul MH, Schwartz AD, Levin DL, Schimdler S (1975) Shortened platelet survival in cyanotic heart disease. J Pediatr 87:77–79

    Google Scholar 

  38. Wedemeyer A, Edson JR, Krivit W (1972) Coagulation in cyanotic congenital heart disease. Am J Dis Child 124:655–660

    Google Scholar 

  39. Wedemeyer A, Lewis JH (1973) Improvement in hemostasis following phlebotomy in cyanotic patients with heart disease. J Pediatr 83:46–50

    Google Scholar 

  40. Zuzel M (1971) ADP-induced aggregation of blood platelets released from clot by fibrinolysis in vitro. Society on Thrombosis and Haemostasis, Oslo, Norway (Abstract), p 278

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Children's Hospital, Moorenstr. 5, D-4000, Düsseldorf, Germany

    W. -R. Thies, U. Göbel & R. Liersch

Authors
  1. W. -R. Thies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Göbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Liersch
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by Land Nordrhein-Westfalen, Ministerium für Wissenschaft und Forschung

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thies, W.R., Göbel, U. & Liersch, R. Fibrinogen half-life in children with cyanotic congenital heart disease. Eur J Pediatr 139, 43–47 (1982). https://doi.org/10.1007/BF00442078

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442078

Key words

Search

Navigation